Oncology Institute (TOIIW) Asset Utilization Ratio (2021 - 2026)

Oncology Institute (TOIIW) has 6 years of Asset Utilization Ratio data on file, last reported at 3.28 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 36.93% year-over-year to 3.28; the trailing twelve-month figure through Mar 2026 stood at 3.28 (up 36.93% YoY), and the FY2025 full-year result was 2.98, up 44.67% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 3.28, up from 3.06 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 3.28 in Q1 2026 and bottomed at 0.93 in Q4 2022.
• The 5-year median for Asset Utilization Ratio is 1.66 (2024), against an average of 1.85.
• The widest annual swing landed in 2022, when Asset Utilization Ratio slipped 1.1%; it then surged 63.82% in 2023.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.93 in 2022, then soared by 63.82% to 1.52 in 2023, then surged by 47.43% to 2.24 in 2024, then jumped by 36.98% to 3.06 in 2025, then rose by 7.06% to 3.28 in 2026.
• The last three Asset Utilization Ratio figures came in at 3.28 (Q1 2026), 3.06 (Q4 2025), and 2.85 (Q3 2025), per Business Quant data.

Peer Comparison